"Designing Growth Strategies is in our DNA"

Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market Size, Share and Industry Analysis by Product Type (Glassia, Aralast NP, Prolastin C, Zemaira/Respreeza), End User (Hospitals, Specialty Clinics) and Regional Forecast, 2019 - 2025

Region : Global | Format: PDF | Report ID: FBI100169

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Final report will be updated to address the impact of COVID-19 on this particular market

Request Sample PDF

Refresh Button
Booklet
  • Apr, 2019
  • 2018
  • 2014-2018
  • 118

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X